Invention Grant
- Patent Title: Anti-S100A8 for treating leukemia
-
Application No.: US15759362Application Date: 2016-09-13
-
Publication No.: US10894082B2Publication Date: 2021-01-19
- Inventor: Philippe Tessier , Malika Laouedj , Frédéric Barabe , Natalie Pagé
- Applicant: UNIVERSITÉ LAVAL
- Applicant Address: CA Québec
- Assignee: UNIVERSITÉ LAVAL
- Current Assignee: UNIVERSITÉ LAVAL
- Current Assignee Address: CA Québec
- Agency: Norton Rose Fulbright
- International Application: PCT/CA2016/051078 WO 20160913
- International Announcement: WO2017/045070 WO 20170323
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/24 ; A61P35/02 ; C07K16/18 ; A61K31/351 ; A61K31/513
Abstract:
The present description relates to an anti-S1008 protein for treating leukemia. More specifically, is disclosed anti-S100A8 antibody that specifically binds to a portion of S100A8 protein and/or a S100A8/S100A9 heterodimer for treating leukemia.
Public/Granted literature
- US20180256710A1 ANTI-S100A8 FOR TREATING LEUKEMIA Public/Granted day:2018-09-13
Information query
